Insiders who have reported open-market trades at the same companies as William P. Forbes. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
William P. Forbes is a corporate insider, tracked as EVP, Chief Development Officer of HERON THERAPEUTICS, INC. /DE/ (HRTX). InsiderAlpha holds 14 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has William P. Forbes submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
William P. Forbes is EVP, Chief Development Officer of HERON THERAPEUTICS, INC. /DE/ (HRTX). 14 SEC Form 4 filings on record going back to 2024, most recently on 3 August 2026.
Recent transactions
17
The latest 17 SEC Form 4 transactions reported by William P. Forbes.
InsiderAlpha's records for William P. Forbes go back to 2024: 14 primary Form 4 filings, an average of 4.7 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
